Comparing PET/MR and MRI for liver tumor detection
Part of Cancer, Digestive system clinical trials.
This study compares two advanced imaging techniques — a combined PET/MR scan and an enhanced MRI — to see which one better finds and shows liver tumors or cancer that has spread to the liver. If you have signs of a liver problem, this trial may help doctors get a clearer picture of your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have symptoms or blood test results (like high alpha-fetoprotein) that suggest a liver tumor or cancer that has spread to the liver.
- You have had other imaging tests (like CT or ultrasound) that also suggest a liver problem.
- You are able to lie still for a PET/MR scan and can follow the study instructions.
- You are not allergic to the contrast dye used in MRI scans.
- You are not pregnant or breastfeeding, and you do not have severe heart, kidney, or liver failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a combined PET and MRI scan (with contrast) can find malignant liver lesions more accurately than a standard PET/CT. If you have a known or suspected liver tumor, this scan might give your doctors clearer images to decide treatment.
This trial uses a special PET scan that targets a protein found in liver cancer cells. It aims to see if this new scan works better than an enhanced MRI to find liver cancer. If you have suspected or confirmed liver cancer, this study might help guide your care.
This study compares different scan types (MRI, CT, and two PET scans) in people with hepatocellular carcinoma (a primary liver cancer). It may help doctors figure out which scan gives the most useful information for diagnosis and treatment planning.
This study looks at how well special imaging scans (PET/CT or PET/MRI) work in adults with suspected or diagnosed liver cancer. It may help doctors better see the cancer and plan next steps.
This trial studies how well a special imaging test (68Ga-FAPI PET/MRI) can detect and evaluate hepatocellular carcinoma (HCC), a type of liver cancer. It may help doctors confirm diagnosis and plan next steps by seeing how the cancer takes up the tracer.
This study uses a special PET/MRI scan with a tracer called PSMA-11 to look at how liver cirrhosis affects the liver. It may help doctors better understand and monitor the disease.
Hear when a new Hepatoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.